Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.

The oncologist - 3 Jun 2024

Boscolo Bielo Luca, Belli Carmen, Crimini Edoardo, Repetto Matteo, Ascione Liliana, Pellizzari Gloria, Santoro Celeste, Fuorivia Valeria, Barberis Massimo, Fusco Nicola, Rocco Elena Guerini, Curigliano Giuseppe

Abstract excerpt

BACKGROUND: Cancer of unknown primary origin (CUP) poses a significant challenge due to poor clinical outcomes and limited treatment options. As such, further definition of clinicopathological factors and genomic profile to better adapt treatment strategies is required. METHODS: Medical records were interrogated to retrospectively include CUP with available clinical and genomics data at the European Institute of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Europe

Share to TP53 gene

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms, Unknown Primary

Source

Open in PubMed Open full text

Identifiers

PMID: 38520742
DOI: 10.1093/oncolo/oyae038
PMCID: PMC11145013

Genes

KRAS
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.PMID 38520742Read ↗

Real-world data analysis of patients with cancer of unknown primarySemantic proximity Read ↗

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.Semantic proximity Read ↗

Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Semantic proximity Read ↗

Cancer of unknown primary.Semantic proximity Read ↗

Comprehensive ctDNA Profiling Enables Tissue-of-Origin Prediction and Actionable Biomarker Detection in Cancer of Unknown PrimarySemantic proximity Read ↗

Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)Semantic proximity Read ↗

Molecular driver alterations and their clinical relevance in cancer of unknown primary site.Semantic proximity Read ↗

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity Read ↗

Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP).Semantic proximity Read ↗

Does genomic profiling improve clinical outcome in carcinoma of unknown primary? - A systematic reviewSemantic proximity Read ↗

Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.